Adaptive Biotechnologies

Adaptive Biotechnologies is a commercial-stage biotechnology company that decodes the adaptive immune system to improve disease diagnosis and therapeutic development. The enterprise operates an immune medicine platform that utilizes high-throughput immune repertoire sequencing to track T-cell and B-cell receptors through clinical assays like clonoSEQ for blood cancer monitoring. By translating immune system receptors into diagnostic insights, Adaptive Biotechnologies enhances patient monitoring and drug discovery.